TABLE OF CONTENTS
INTRODUCTION
The Joy of Collegiality in the Return to Deep Science Robert E. Henry
Challenges in Drug Development: 100 Years of Diabetes Management Thomas McCarter, MD, FACP; Keri Cooper; Alicia Mettimano
The Role of New Healthcare Technologies in a National Wellness Strategy Robert K. Smoldt, BS, MBA
Value-Based Benefit: The Concept, the Reality, and the Challenge Gary M. Owens, MD
Employers’ Perspective on New Technologies in Healthcare F. Randy Vogenberg, RPh, PhD
Employers’ Perspective on Value in Healthcare Innovation Wayne M. Lednar, MD, PhD
Value-Based Purchasing: Impact on Pharma Lawton Robert Burns, PhD, MBA
The New, Risk-Averse World of Regulation and Reimbursement Kip Piper, MA, CHE
Evidence Standards in the Era of Comparative Effectiveness Nirav R. Shah, MD, MPH
The Role of Epidemiology in New Drug Development Jeff J. Guo, BPharm, PhD; Christina M. L. Kelton, PhD
Impact of Market Trends on Drug Pipelines: The Need for Value-Based R&D Matthew Sarnes, PharmD
Case Study: Insu-Nectin (NV 1008) for Type 2 Diabetes Michael F. Murphy, MD, PhD